Black Women Have Higher Incidence of Multiple Sclerosis than White Women

PASADENA, Calif., May 6, 2013 /PRNewswire/ -- Multiple sclerosis is more common in black women than in white women, according to a Kaiser Permanente study published today in the journal Neurology. The findings run contrary to the widely accepted belief that blacks are less susceptible to MS, according to the researchers.

Researchers examined the electronic health records of more than 3.5 million members of Kaiser Permanente Southern California between January 2008 and December 2011 and identified 496 people newly diagnosed with MS. Of these diagnosed cases, black patients had a 47 percent higher risk of MS than white patients, while Hispanic and Asian patients had a 50 percent and 80 percent lower risk compared to white patients, respectively.

The study also found that 70 percent of MS cases occurred in females, but this preponderance of females diagnosed was more pronounced among black patients than white patients. In addition, black women had a higher incidence of MS than white patients of both genders, while black men had a similar risk of being diagnosed with MS compared to white men. The lower risk among Hispanic and Asian patients was true for both sexes.

"Our findings do not support the widely held belief that blacks have a lower risk of MS than whites, but that MS risk is determined by complex interactions between race, ethnicity, sex, environmental factors and genotypes," said study lead author Annette Langer-Gould, MD, PhD, of the Kaiser Permanente Southern California Department of Research & Evaluation. "Although additional research is needed, possible explanations for the higher incidence of MS in black women include a greater prevalence of hormonal, genetic, or environmental risk factors such as smoking, compared to patients from other racial or ethnic groups."

The study estimates 19,000 people per year — or 250 per week — are newly diagnosed with MS in the U.S. The researchers identified the average age of MS diagnosis as 41.6 years, but found onset occurred anywhere between 8.6 and 78.3 years among the study participants. The study also found the median time from symptom onset to MS diagnosis was four months, but could be as long as 40 years. Hispanic and Asian patients were generally younger at the time of MS diagnosis than white and black patients.

According to the researchers, the belief that MS is rare in blacks is based on worldwide prevalence studies and a single study of Korean War veterans in the 1950s, which found white men were twice as likely to receive disability compensation for MS as black men. "A possible explanation for our findings is that people with darker skin tones have lower vitamin D levels and therefore an increased risk of MS. However, this does not explain why Hispanics and Asians have a lower risk of MS than whites, or why only black women but not black men are at a higher risk of MS," said Dr. Langer-Gould. "Our findings indicate that including persons from different racial and ethnic groups in future studies of MS susceptibility and prognosis will likely reveal important insights into the causes of this often debilitating disease."

The National MS Society defines MS as a chronic, often disabling disease that attacks the central nervous system, which is made up of the brain, spinal cord and optic nerves. Symptoms may be mild, such as numbness in the limbs, or severe, such as paralysis or loss of vision. The progress, severity and specific symptoms of MS are unpredictable and vary from one person to another. The organization estimates that more than 2.1 million people are affected by MS worldwide. Because the Centers for Disease Control and Prevention does not require U.S. physicians to report new cases of MS and symptoms can be invisible, the prevalence of MS in the U.S. can only be estimated.

This study is part of Kaiser Permanente's ongoing efforts to study its highly diverse and representative member population as a way to better understand chronic diseases like multiple sclerosis. In January, a Kaiser Permanente study published in the journal Neurology found obesity in teenage girls was associated with an increased risk of developing MS. Researchers are also currently recruiting patients for the MS Sunshine Study to examine the complex interactions between MS risk factors such as sunshine, low vitamin D, skin tone, infections, other environmental and genetic factors across racial/ethnic groups. Researchers expect to release findings of this study in 2015.

Kaiser Permanente can conduct transformational health research like this study in part because it has the largest private electronic health system in the world. The organization's integrated model and electronic health record system, Kaiser Permanente HealthConnect®, securely connects 9 million people, 611 medical offices, and 37 hospitals, linking patients with their health care teams, their personal health information and the latest medical knowledge. It also connects Kaiser Permanente's research scientists, clinicians and operational leaders to one of the most extensive collections of longitudinal medical data available, facilitating studies and important medical discoveries that shape the future of health and care delivery for patients and the medical community.

Other study authors included: Sonu M. Brara, MD, and Brandon E. Beaber, MD, of the Kaiser Permanente Southern California Los Angeles Medical Center, Neurology Department; and Jian L. Zhang, MS, of the Kaiser Permanente Southern California Department of Research & Evaluation.

About the Kaiser Permanente Southern California Department of Research & Evaluation 
The Department of Research & Evaluation conducts high-quality, innovative research into disease etiology, prevention, treatment and care delivery. Investigators conduct epidemiology, health sciences and behavioral research as well as clinical trials. Areas of interest include diabetes and obesity, cancer, HIV/AIDS, cardiovascular disease, aging and cognition, pregnancy outcomes, women's and children's health, quality and safety, and pharmacoepidemiology. Located in Pasadena, Calif., the department focuses on translating research to practice quickly to benefit the health and lives of Kaiser Permanente members and the general population. Visit www.kp.org/research.

About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We serve more than 9 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to kp.org/newscenter.

For more information:
Vincent Staupe, [email protected], 415.318.4386
Sandra Hernandez-Millett, [email protected], 626.405.5384

SOURCE Kaiser Permanente